Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Bio Key International (BKYI) over the last 16 years, with Q3 2025 value amounting to -$1325.0.

  • Bio Key International's Cash from Investing Activities rose 9374.35% to -$1325.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2627.0, marking a year-over-year increase of 11092.44%. This contributed to the annual value of -$13047.0 for FY2024, which is 120470.0% down from last year.
  • Per Bio Key International's latest filing, its Cash from Investing Activities stood at -$1325.0 for Q3 2025, which was up 9374.35% from -$1478.0 recorded in Q2 2025.
  • In the past 5 years, Bio Key International's Cash from Investing Activities registered a high of $10000.0 during Q4 2024, and its lowest value of -$545037.0 during Q1 2022.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$4570.0 (2025), whereas its average is -$50670.8.
  • As far as peak fluctuations go, Bio Key International's Cash from Investing Activities plummeted by 399586.68% in 2022, and later skyrocketed by 110000.0% in 2024.
  • Over the past 5 years, Bio Key International's Cash from Investing Activities (Quarter) stood at -$4141.0 in 2021, then plummeted by 3062.86% to -$130974.0 in 2022, then soared by 99.24% to -$1000.0 in 2023, then surged by 1100.0% to $10000.0 in 2024, then plummeted by 113.25% to -$1325.0 in 2025.
  • Its last three reported values are -$1325.0 in Q3 2025, -$1478.0 for Q2 2025, and -$4570.0 during Q1 2025.